Online application for the diagnosis of atherosclerosis by six genes

Zunlan Zhao1, Shouhang Chen2, Hongzhao Wei3

  • 1Department of General Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Plos One
|April 10, 2024
PubMed

Insights

This study developed an accurate atherosclerosis (AS) diagnostic model using blood gene expression data. The accessible Shiny app aids early detection and prognosis of AS, a major cardiovascular disease risk.

Area of Science:

  • Biomedical Informatics
  • Cardiovascular Research
  • Genomics

Background:

  • Atherosclerosis (AS) is a leading cause of cardiovascular disease mortality globally.
  • Early detection and accurate diagnostic models for AS are crucial for reducing fatalities.
  • Blood sample analysis offers a promising, yet currently lacking, accurate tool for AS diagnosis and prognosis.

Purpose of the Study:

  • To develop a convenient, simple, and accurate model for the early detection of atherosclerosis.
  • To identify key genes associated with AS through differential gene expression analysis.
  • To create a publicly accessible tool for AS diagnosis.

Main Methods:

  • Downloaded and preprocessed blood sample expression data from GEO databases, including batch effect correction.
  • Performed differential expression analysis (DEA) to identify atherosclerosis-related genes.
  • Utilized gradient boosting and random forest models for gene importance evaluation and prediction model construction.

Main Results:

  • Integrated seven datasets comprising 403 AS and 325 healthy samples.
  • Identified 331 atherosclerosis-related genes, with the top 6 highlighted by gradient boosting.
  • The random forest model achieved an accuracy exceeding 0.8 in predicting AS, outperforming existing methods.

Conclusions:

  • Developed a prognostic Shiny application based on six atherosclerosis-associated genes.
  • The application provides accurate diagnosis for atherosclerosis.
  • The tool facilitates distinguishing AS samples from normal samples for improved patient outcomes.
Abstract